Immune Design Reports Data Update for Lead Immunotherapy Programs: Improvement in Survival for CMB305 …NasdaqSEATTLE and SOUTH SAN FRANCISCO, March 12, 2018 (GLOBE NEWSWIRE) — Immune Design (Nasdaq:IMDZ), an immunotherapy company focused on next-gen… Continue reading
PR Newswire (press release)OncoSec Announces Publication In Nature Gene Therapy Demonstrating Efficacy Of IL-12 Intratumoral Gene …PR Newswire (press release)SAN DIEGO, March 12, 2018 /PRNewswire/ — OncoSec Medical Incorporated (OncoSec) (NASDAQ: … Continue reading
Immune Design (IMDZ) Announces Data Update for Lead Immunotherapy ProgramsStreetInsider.comImmune Design (Nasdaq: IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced updated data from two separate trials ev… Continue reading
Parkinson’s News Today |
Voyager’s Gene Therapy Improves Parkinson’s Patients’ Movement Over Long Term, Trial Shows
Parkinson’s News Today A single administration of Voyager Therapeutics gene therapy improves advanced Parkinson’s patients’ movement up to three years later, a Phase 1b trial indicates. Voyager designed VY-AADC01 to deliver the aromatic L-amino acid decarboxylase (AADC) gene … |